Accueil / Communiqués / Global Bioreactors Market to 2027 – Dominated by Merck, Applikon Biotechnology and Thermo Fisher Scientific –

Global Bioreactors Market to 2027 – Dominated by Merck, Applikon Biotechnology and Thermo Fisher Scientific –

Friday, March 15th 2019 at 4:00pm UTC

DUBLIN–(BUSINESS WIRE)– The « Bioreactors
Market to 2027- Global Analysis and Forecasts by Product Class;
Application; Process; and Geography »
report has been added to’s

The global bioreactors market is expected to reach US$ 4,811.5 Mn in
2027 from US$ 2,850.2 Mn in 2018. The market is estimated to grow with a
CAGR of 6.3% from 2019-2027.

The growth of the bioreactors market is primarily attributed to the
increasing investments in R&D and other activities. Moreover, the rapid
growth of pharmaceutical and biotechnology industry is also expected to
drive the growth of bioreactors market. However, availability of
alternative techniques for bioreactors and stringent regulatory
framework is expected to obstruct the growth of bioreactors market.

On the other hand, rapid use of single use bioreactors are expected to
be trending in the manufacturing companies and research institutes in
the market. The single-use bioreactors are helpful in providing
next-generation cell- and gene-therapies and continuous bioprocessing.
The betterments and improvements in cell-culture processes have
developed higher titers and cell densities, which have facilitated the
adoption of single-use bioreactors through reductions in needed reactor

Single-use bioreactors reduce the risks of contamination from the other
products and decrease production turnaround times. Moreover, reduction
in validation time shortens time which is a tremendous value for the
advanced development of the bio products. The S.U.B. combines elements
of stirred-tank systems with the efficiencies in cleanup and validation
found in single-use processing, and supports scale-up needs and optimal
cell growth, viability, and general metabolism.

In 2018, the industrial scale (>1000L) bioreactors segment held a
largest market share of 63.4% of the bioreactors market, by product
class. This segment is also expected to dominate the market in 2027
owing to increasing demand for industrial scale (>1000L) bioreactors in
biotechnology and pharmaceutical companies. However, the pilot scale (15
– 1000L) bioreactors segment is anticipated to witness the fastest
growth rate of 6.8% during the forecast period, 2019 to 2027 owing to
the increased use of pilot scale bioreactors for research purposes.

Global bioreactors market, based on application was segmented into
microbial application and cell culture. Microbial application segment is
anticipated to grow at a CAGR of 6.5% during the forecast period. The
production of microbiologic and increasing government funding as well as
promotional initiatives undertaken for usage of microbial products to
treat medical conditions. Increasing R&D innovation in various other
microbial applications has also been contributing significantly to the
growth of the bioreactors market.

Some of the major primary and secondary sources for bioreactors included
in the report are World Health Organization (WHO), International
Federation of Pharmaceutical Manufacturers & Associations (IFPMA),
National Research Foundation (NRF), Biotechnology Industry Research
Assistance Council (BIRAC), Canadian Institutes of Health Research
(CIHR) and others.

Topics Covered

1. Introduction

1.1 Scope of the Study

1.2 Report Guidance

1.3 Market Segmentation

1.3.1 Global Bioreactors Market – by Product Class

1.3.2 Global Bioreactors Market – by Application

1.3.3 Global Bioreactors Market – by Process

1.3.4 Global Bioreactors Market – by Geography

2. Global Bioreactors Market – Key Takeaways

3. Research Methodology

3.1.1 Coverage

3.1.2 Secondary Research

3.1.3 Primary Research

4. Global Bioreactors Market – Market Landscape

4.1 Overview

4.2 Pest Analysis

4.2.1 North America – Pest Analysis

4.2.2 Europe – Pest Analysis

4.2.3 Asia Pacific – Pest Analysis

4.2.4 Middle East & South Africa – Pest Analysis

4.2.5 South and Central America – Pest Analysis

5. Global Bioreactors Market – Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Increased Acceptance of Single-Use Bioreactors

5.1.2 Rapid Growth of Pharmaceutical and Biotechnology Industry

5.1.3 Increasing Investments In R&D and Other Activities

5.1.4 Technological Advancements In Bioreactors

5.2 Key Market Restraints

5.2.1 Stringent Regulatory Framework

5.2.2 Availability of Alternative Techniques For Bioreactors

5.3 Key Market Opportunities

5.3.1 High Market Potential In Emerging Economies

5.3.2 Rising Demand of Personalized Medicine

5.4 Future Trends

5.4.1 Rapid Adoption of Ionic Liquids

5.5 Impact Analysis

6. Bioreactors Market – Global Analysis

6.1 Global Bioreactors Market Revenue Forecasts and Analysis

6.2 Global Bioreactors Market, by Geography – Forecasts and Analysis

6.3 Performance of Key Players

6.3.1 Merck KGaA

6.3.2 Applikon Biotechnology B.V.

6.3.3 Thermo Fisher Scientific Inc.

6.4 Expert Opinions

7. Global Bioreactors Market Analysis – by Product Class

7.1 Overview

7.2 Global Bioreactors Market by Product Class, 2018 & 2027 (%)

7.3 Benchtop Bioreactors (Up To 15L) Market

7.4 Pilot Scale Bioreactors (15-1000L) Market

7.5 Industrial Scale Bioreactors (>1000L) Market

8. Global Bioreactors Market Analysis – by Application

8.1 Overview

8.2 Global Bioreactors Market, by Application 2018 & 2027 (%)

8.3 Microbial Application Market

8.4 Cell Culture Market

9. Global Bioreactors Market Analysis – by Process

9.1 Overview

9.2 Global Bioreactors Market, by Process 2018 & 2027 (%)

9.3 Research & Development Market

9.4 Process Development Market

9.5 Bioproduction Market

10. Bioreactors Market Revenue and Forecasts To 2027 – Geographical

10.1 North America Bioreactors Market

10.2 Europe Bioreactors Market

10.3 Asia Pacific Bioreactors Market

10.4 Middle East & Africa Bioreactors Market

10.5 South and Central America Bioreactors Market

11. Bioreactors Market – Industry Landscape

11.1 Overview

11.2 Comparative Company Analysis

11.3 Growth Strategies In the Bioreactors Market, 2015-2018

11.4 Organic Growth Strategies

11.4.1 Overview

11.4.2 Expansions

11.4.3 Product Launches

11.4.4 Other Organic Growth Strategies

11.5 Inorganic Growth Strategies

11.5.1 Overview

11.5.2 Agreements

11.5.3 Acquisitions

11.5.4 Other Inorganic Growth Strategies

12. Bioreactors Market – Key Company Profiles

12.1 Merck KGaA

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Financial Overview

12.1.4 Product Portfolio

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Applikon Biotechnology B.V.

12.3 Thermo Fisher Scientific Inc.

12.4 Eppendorf

12.5 Bioengineering AG

12.6 Solaris Biotechnology Srl

12.7 Praj Industries

12.8 Sartorius AG

12.9 Danaher (Pall Corporation)

12.10 General Electric

For more information about this report visit

Laura Wood, Senior Press Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Topics: Biotechnology

Source: Research and Markets

Voir aussi

Poxel Reports Financial Results for Full Year 2018 and Provides Corporate Update

Thursday, March 21st 2019 at 4:45pm UTC Executed strategic agreement for Imeglimin with Roivant Sciences; …